CARGO Therapeutics, Inc. Common Stock (CRGX NASDAQ) stock market data APIs
$4.5713
-0(-0%)
as of July 11, 2025
Try our APIs with
free plan!
CARGO Therapeutics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States. The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.
Prev. Close
4.5713
Open
4.5663
High
4.6121
Low
4.5254
52 wk Range
3-25.45
Market Cap
214 M
Shares Outstanding
46 517 K
EPS
-1.77
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CARGO Therapeutics, Inc. Common Stock data using free add-ons & libraries
Get CARGO Therapeutics, Inc. Common Stock Fundamental Data
CARGO Therapeutics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -185 932 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: -1.17
Get CARGO Therapeutics, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CARGO Therapeutics, Inc. Common Stock News
New
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX)
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX and WNS on Behalf of Shareholders
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or bre...
Noteworthy Tuesday Option Activity: FCX, GNL, CRGX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Freeport-McMoran Copper & Gold (Symbol: FCX), where a total of 109,197 contracts have trade...
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition
Investing.com - Jefferies raised its price target on Cargo Therapeutics (NASDAQ:CRGX) to $5.00 from $3.70 while maintaining a Hold rating, following the company’s acquisition announcement. The stock...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
